Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis

Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing- remitting multiple sclerosis (RRMS) and interferes with immune cell migration into the central nervous system by blocking the α(4) subunit of very-late activation antigen-4 (VLA-4). Although well tolerated and ve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harrer, Andrea, Pilz, Georg, Einhaeupl, Max, Oppermann, Katrin, Hitzl, Wolfgang, Wipfler, Peter, Sellner, Johann, Golaszewski, Stefan, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3282779/
https://ncbi.nlm.nih.gov/pubmed/22363732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0031784
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados